| IMMURON LTD SPON.ADR 40 |
| USA |
| Gesundheit |
| US45254U1016 / A2DTD8 |
| ANWA (Frankfurt) / IMRN (NASDAQ) |
| FRA:ANWA, ETR:ANWA, ANWA:GR, NASDAQ:IMRN |
| - |
| https://www.immuron.com.a.. |
|
Immuron Ltd Sponsored ADR represents a foreign entity, Immuron Limited, which is an Australian-based biopharmaceutical company. This asset allows U.S. investors to indirectly own shares of Immuron without the complexities often associated with intern..
>Volltext.. |
| 5.47 Mio. EUR |
| -0.3 Mio. EUR |
| 4.18 Mio. EUR |
| - |
| -2.59 Mio. EUR |
| -0.42 EUR |
| - |
| 5.77 Mio. EUR |
| -2.45 Mio. EUR |
| 5.39 |
| 11.9% |
| 38.35% |
| - |
| - |
| - |
| - |
| IMMURON ADR, IMMURON |
| 05.04.26 |
|